CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3/4, Prospective, Multinational, Open-label, Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01597596
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:01.286571+00:00
Published At: 2016-01-18T00:00:00+00:00
Record Updated At: 2016-01-18
Results Posted At: 2016-01-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pompe Disease (Infantile-Onset)", "Glycogen Storage Disease Type II (GSD II)", "Glycogenosis 2", "Acid Maltase Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-18"
protocolSection.identificationModule.nctId: "NCT01597596"
protocolSection.identificationModule.officialTitle: "A Phase 3/4, Prospective, Multinational, Open-label, Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Na\u00efve Patients With Infantile-Onset Pompe Disease"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-01-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.